are glp 1 compounds still available Risky off-brand GLP-1 drugs become affordable option with history of safety issues Hims & Hers stock falls

At approximately $1,999 per month through MEDVi, this option is significantly more expensive and primarily appeals to patients whose insurance does not cover weight loss medications but who still want the assurance of a brand-name, FDA-approved product

Who this service is for This programme is for individuals who are ready to begin, or continue, GLP-1 therapy within a structure that supports aesthetic longevity and long-term safety

Frequently asked questions Why is subcutaneous L-Carnitine preferred over oral supplements

[17] In November 2025, Pfizer won a bidding war with Novo Nordisk, acquiring obesity drug developer, Metsera